BREAST CANCER NIEHS scientists co-discovered the first breast cancer gene, BRCA1, and played a role in the multi-national discovery of BRCA2. Together, these genes may account for much familial breast cancer, the kind that clusters in some families. The genes may be involved in 5 to 10 percent of all breast cancer - and a higher percentage of early breast cancers (affecting women under 45). A test has been devised to identify women carrying the defective BRCA1 gene. In another attack on this multi-faceted disease, NIEHS is studying a growth factor called transforming growth factor alpha that responds to the female hormone estrogen and may play a role in normal breast development - and could lead to new ways to detect breast cancer. Grantees are studying the possible role of pesticides that may mimic some of the activity of estrogen. Institute scientists also collaborated on a study that showed that late first pregnancy and late menopause were associated with a higher risk of breast cancer, while women with four or more pregnancies had a significantly lower risk. Environmental estrogens are a variety of synthetic chemicals and natural plant compounds that are thought to mimic the female hormone estrogen. They may act like estrogens or may block the natural hormone. The body's estrogen controls the growth of cells by attaching to proteins called estrogen receptors throughout the body. Many environmental estrogens can attach to these same proteins, fooling the body or tissues by giving them an inappropriate "estrogen" signal. These compounds are found all around us. We eat them, drink them, breathe them and use them at work, at home and in the garden. They include pesticides such as the now-banned DDT; kepone, polychlorinated biphenyls (PCBs), natural plant products in our diet, and the drug DES, which was widely used for more than 20 years beginning in the 1940s to prevent spontaneous abortions in women. In 1971, researchers showed that daughters of women who took DES had a high rate of a rare form of cervicovaginal cancer. DES' common use as a growth promoter in cattle also was banned by the Food and Drug Administration in the 1970s. NIEHS is supporting and conducting studies of environmental estrogen exposures, including a testing of the blood and urine of a representative group of Americans to determine how much of these chemicals are accumulating in the body . There is a possibility they might play a role in diseases such as cancers of the breast, uterus and ovaries; endometriosis and uterine fibroids. There is also a possibility that some of these estrogen-like substances, such as the ones occurring naturally in vegetables, may be beneficial.
|